WeVote

Bill

Bill

S 2013

Higher Wages for American Workers Act of 2025

119th Congress Introduced by Ruben Gallego and 2 co-sponsors

Bill S 2013 criminalizes the sale, use, and possession of synthetic drugs, aiming to enhance public safety and health by imposing legal penalties on offenders.

Introduced in Senate
0
WeVote Research Nonpartisan
Bill Summary · S 2013

Summary of Bill S 2013

Bill Information

  • Bill Number: S 2013
  • Title: Relates to criminalizing the sale, use, and possession of synthetic drugs
  • Status: Referred to Codes
  • Introduced: January 14, 2025
  • Classification: Bill

Purpose and Intent

Bill S 2013 aims to address the growing concern over synthetic drugs, which have been linked to various health risks and criminal activities. The bill seeks to criminalize the sale, use, and possession of these substances, thereby enhancing public safety and health protections.

Key Provisions

The bill includes several important provisions:

  1. Criminalization of Synthetic Drugs:

    • The bill proposes to make it illegal to sell, use, or possess synthetic drugs, which are often designed to mimic the effects of controlled substances but can be more potent and dangerous.
  2. Definition of Synthetic Drugs:

    • The legislation will define what constitutes synthetic drugs, ensuring clarity in enforcement and legal proceedings.
  3. Penalties:

    • Specific penalties for violations will be established, which may include fines and imprisonment, although exact amounts and terms will be detailed in subsequent legislative discussions.
  4. Enforcement Measures:

    • The bill will outline the roles of law enforcement agencies in monitoring and enforcing the new regulations concerning synthetic drugs.

Who Would Be Affected

  • Individuals: The bill directly impacts individuals who may use, sell, or possess synthetic drugs, subjecting them to legal penalties.
  • Law Enforcement: Agencies will be tasked with enforcing the new regulations, requiring additional training and resources.
  • Healthcare Providers: Increased cases of synthetic drug-related health issues may affect healthcare providers and emergency services.

Procedural Aspects

  • Current Status: As of January 14, 2025, the bill has been referred to the Codes Committee for further consideration and discussion.
  • Related Bills: This bill is part of a broader legislative effort, with several related bills from prior sessions (S 5888, S 738, S 118, S 2692, S 595) indicating ongoing legislative attention to the issue of synthetic drugs.

Conclusion

Bill S 2013 represents a significant step towards addressing the challenges posed by synthetic drugs. By criminalizing their sale, use, and possession, the bill aims to protect public health and safety. As the bill progresses through the legislative process, further details regarding penalties and enforcement will be clarified.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.